Background: This study aimed to determine the impact of socio-economic and geographic disparities on disease stage at diagnosis according to age in breast cancer (BC) patients. Secondary purpose was to describe survival. Methods: All women with primary invasive BC, diagnosed from 1998 to 2009 in the department of Cô te d'Or were retrospectively selected using data from the Cô te d'Or BC registry. European transnational ecological deprivation index (French European Deprivation Index) was used to measure the socio-economic environment. Relationships between socio-geographic deprivation and disease stage at diagnosis according to age were assessed by a multilevel ordered logistic regression model. Relative survival rates (RSRs) were given at 5 years according to tumour and patients characteristics. Results: In total, 4364 women were included. In multivariable analysis, socio-economic deprivation was associated with disease stage at diagnosis. Women aged between 50 and 74 years and living in deprived areas were more often diagnosed with advanced tumour stages (stages II/III vs. I or stages IV vs. II/III) with odds ratio = 1.27 (1.01-1.60). RSRs were lowest in women living in the most deprived area compared with those living in most affluent area with RSR = 88. 4% (85.9-90.4) and 92.6% (90.5-94.2), respectively. Conclusions: Socio-economic factors affected tumour stage at diagnosis and survival. Living in a deprived area was linked to advanced-stage BC at diagnosis only in women aged 50-74 years. This is probably due to the socioeconomic disparities in participation in organized BC screening programmes. Furthermore, living in deprived area was associated with a poor survival rate.
Introduction

B
reast cancer (BC) has a relatively good prognosis; the net survival rate at 5 years was 89% for cancers diagnosed from 2001 to 2004 in France. 1 This prognosis was closely associated with the cancer stage at diagnosis and access to care after the diagnosis. 2 Early detection is essential to reduce BC mortality. Indeed, screening can detect cancers at an early stage, allowing more effective treatment. 3 In France, the organized screening programme involves sending by the structure in charge of the organization of screening in each department, an invitation to conduct a free of charge screening mammogram at all women aged 50-74 years every 2 years. This programme was generalized to all departments in 2004, for women aged 50-74 years. A national average participation rate of 58% was reported in 2013 with an average participation of 58.7% in the department of Cô te d'Or. 4 However, with the aging population and the increase in life expectancy, BC is largely a disease of older women. 5 In France, in 2012, higher incidence rates of BC were reported in women aged 65 years and older. 2 The management of BC in this age group can be challenging with the presence of comorbidities and concomitant medication, 6 which could interact with diagnosis stage, treatment or survival in BC.
Furthermore, several reports have suggested strong socioeconomic and geographic inequalities in the stage of the disease at diagnosis and in survival in women with BC in developing countries and in the United States. Indeed, differences in cancer burden, disease stage, treatment, survival and outcome among population groups have been found to be closely related to key social and economic characteristics such as education, poverty level, social and physical environments, health behaviour and availability of health care services. 7, 8 However, faced with the difficulties of routinely collecting individual socio-economic data (level of education, income, etc.), especially in cancer registries, several studies used neighbourhood socioeconomic position data to examine associations between socioeconomic position and health. 9, 10 Studies conducted in the United states, Sweden and China over the past decade have indicated that individuals living in less developed areas often had worse general health compared with individuals living in relatively developed areas. [11] [12] [13] [14] Some studies performed in Pakistan and Australia also showed that rates of advanced-stage BC were higher in women living in deprived areas and in remote areas. 7, 15 In addition, previous studies have shown that cancer survival tends to be poorer in low socio-economic groups compared with high socio-economic groups. 16, 17 To our knowledge, few studies have reported data about the link between the socio-economic level of an area and disparities in cancer stage at diagnosis according to age, and none have been conducted using French population-based data. Furthermore, the Cô te d'Or BC registry offers a unique opportunity to assess the impact of socioeconomic level on relative survival in a large comprehensive population and over a long period of time.
The purpose of this study was to identify socio-economic and geographic determinants on disease stage at diagnosis according to age in BC patients. Secondary purpose was to describe survival according to tumour and patient's characteristics including socioeconomic and geographic variables.
Methods
Population
A population-based study was undertaken using data from the Cô te d'Or breast and gynaecological cancer registry. This registry has been collecting data on all patients with newly diagnosed breast and gynaecological cancer since 1982. The registry catchment area has approximately 500 000 inhabitants, including about 270 000 women. The population of Cô te d'Or is predominantly rural with low migration. All cases of BC occurring in residents of Cô te d'Or at the time of diagnosis are collected in the registry database. The management of patients with BC in the department is multidisciplinary and is centralized mainly in Dijon, which has a comprehensive cancer care centre (60% of patients of the registry), a University Hospital and some private hospitals. 18 Women with invasive BC diagnosed in the years 1998-2009 and residing in Cô te d'Or at the date of diagnosis were identified from the Côte d'Or breast and gynaecological cancer registry database. Women with in situ BC or those for whom the only information was that given on the death certificate only (DCO) were excluded. For patients with synchronous bilateral BC, the most advanced tumour according to the number of positive nodes, the tumour size, the Scarff, Bloom and Richardson grade and the tumour histology was included.
Studied variables and endpoints
Social and geographic variables included place of residence (rural/ urban), distance from the place of residence to the nearest cancer radiology centre (categorized according to tertiles: <2 km, 2-8 km and !9 km) and the French European Deprivation Index 19 (FEDI), which is an index to measure the socio-economic environment. FEDI tertiles were obtained by geocoding the residence address in small geographical units, Merged Islet for Statistical Information (MISI). These MISI were used to classify social deprivation, with tertile 1 being the most affluent and tertile 3 the most deprived area. The score of the FEDI for a geographical unit is calculated using the following variables: overcrowding, no access to a system of central or electric heating, non-owner, unemployment, foreign nationality, no access to a car, unskilled worker-farm worker, household with six or more persons, low level of education (less than first stage of secondary-level education) and single-parent household. The other studied variables were age at diagnosis, which was categorized into three classes: <50 years, 50-74 years and >74 years to take into account the age group (50-74 years) affected by the organized BC screening program in France, the tumour stage which was the outcome of the study (categorized according to the American Joint Committee on Cancer TNM (Tumour Nodes Metastasis) staging system version 5 into early stage: stage I, middle stage: stages II+III and advanced stage: stage IV), diagnosis circumstances (clinical signs, medical imaging = opportunistic and/or organized screenings) and comorbidities. The comorbidities were collected at the diagnosis, as all the diseases associated with BC at the time of diagnosis: diabetes, high blood pressure, neurological disease (Alzheimer, Parkinson, epilepsy), psychiatric illness, tuberculosis, thyroid disorder, genetic abnormalities and a previous history of disease that affected treatment (renal disease, heart failure). Comorbidities were classified into two categories: at least one comorbidity and no comorbidity. To take into account progress in diagnosis, with the introduction of massscreening campaigns for BC in women aged 50-74 years in 2004 in Cô te d'Or, the period of diagnosis was split into two: 1998-2003 and 2004-2009. Survival was calculated from the date of diagnosis until the date of death or the date of last follow-up. The cut-off date for the survival analysis was set at 1 January 2010. Patients who were alive after the cut-off date were censored.
Statistical methods
Qualitative variables were described as percentages. The percentage of missing values was also provided. Variables were compared according to the FEDI tertile (Most affluent, Middle and Most deprived) and age classes using Chi square and Cochran-Armitage trend tests.
The socio-economic determinants for stage at diagnosis were identified by a multilevel ordered logistic regression analyses. First level data were individual data and second level data were aggregated data (FEDI for MISI). All variables with a univariable P value < 0.20 were eligible for multivariable analyses. Correlations and interactions were tested for eligible variables. To prevent collinearity, when there was a significant correlation between two variables, one variable was retained according to its clinical relevance or to the value of the likelihood ratio. Parameter estimates are presented as odds ratios (ORs) with their 95% confidence intervals (CIs).
All reported P values are two sided. The statistical significance level was set at P < 0.05.
Relative survival is an estimator of the excess mortality ratio. The excess mortality ratio is the ratio of the observed number of deaths to the expected number of deaths estimated from the expected survival probability. Expected survival was estimated using age and period matched mortality rates based on Cô te d'Or female life expectancy tables. Relative survival rates (RSRs) were estimated at 1 year and 5 years according to patients and tumours characteristics. Survival estimates were evaluated for a statistically significant trend over time by comparing their CIs. If the CIs did not overlap, then the difference in the relative survival estimates was statistically significant.
Analyses were done using SAS version 9.3 (SAS Institute, Cary, NC) and STATA version 13.0 (StataCorp, College Station, TX).
Results
Patients' characteristics
A total of 4364 women with BC were retained for the study. Median age at diagnosis was 60 years (range: 25-99 years). The majority of the women in our study was diagnosed with clinical signs (52%), with an early tumour stage (46%), had hormone receptor-positive tumours (84.9%) and lived in urban areas (65.4%). Six hundred and thirty-five MISI were identified with our population residence address. A total of 38.1% lived in the most affluent areas. The proportion of older women living in the most deprived area was higher than the ones living in the most affluent area. Women living in the most deprived areas were more frequently diagnosed with stage IV disease, were more frequently diagnosed by clinical signs, had more comorbidities and were more likely to live in urban areas than were other women (P 0.01) (table 1). Concerning age, the proportion of women with advanced stage (stage IV), diagnosed from 2004 to 2009, with comorbidities, living in an urban area and living near to a cancer radiology centre increased with age (P 0.02). The proportion of women diagnosed by medical imaging was higher for those aged 50-74 years (P = 0.0004) (table 2).
Multilevel socio-economic and geographic determinants
All population
Multivariable ordered multilevel analysis showed that the risk of advanced-stage disease at diagnosis was higher in the oldest age group (>74 years), OR = 1.39, 95% CI = (1.11-1.74) and in those who lived in the most deprived areas, OR = 1.22, 95% CI = (1.02-1.46) (stages II/III vs. I or stages IV vs. II/III). For women with comorbidities, the risk to be diagnosed with advanced stage than with earlier stage was OR = 1.36, 95% CI = (1.17-1.58). The risk was lower in women who were diagnosed on medical imaging than in those diagnosed in clinical circumstances with OR = 0.22, 95% CI = (0.19-0.26) (table 3).
According to age groups
Multivariable ordered multilevel analyses showed that in women younger than 50 years, diagnosis on medical imaging was linked to the BC stage at diagnosis OR = 0.34, 95% CI = (0.25-0.46) and the presence of comorbidities was associated with a higher risk of advanced stages at diagnosis OR = 1.51 (1.12-2.05) (stages II/III vs. I or stages IV vs. II/III).
For women aged between 50 and 74 years, being diagnosed by medical imaging was associated with a lower risk of advanced-stage disease, OR = 0.19 (0.15-0.23). The presence of comorbidities was associated with a higher risk of advanced stages at diagnosis OR = 1.41 (1.17-1.72). Women aged between 50 and 74 years and living in the most deprived area were more frequently diagnosed with an advanced stages, OR = 1.27 (1.01-1.60) (stages II/III vs. I or stages IV vs. II/III).
In older women, the diagnosis circumstances had an effect on the stage at diagnosis with OR = 0.20 (0.14-0.31) and diagnosed from 2004 to 2009 was associated with a higher risk of advanced-stage OR = 1.39 (1.01-1.91) (stages II/III vs. I or stages IV vs. II/III) (table 3) .
Relative survival
The median follow-up was 5.5 years with 95% CI (5.2-5.7). At the cut-off, 773 deaths (18%) had occurred. RSR at 5 years for the whole population was 90.4% (89.0-91.5). Table 4 describes RSR at 5 years according to the socio-economic, geographic and tumour characteristics. The 5-year RSRs were lowest The presence of comorbidities and diagnosis by clinical sign were associated with poor survival rates at 5 years. Period of diagnosis, distance from a diagnosing facility and the place of residence had no effect on 5-year RSRs.
Discussion
This article assessed the association between socio-economic geographic disparities and the stage at diagnosis in BC women, by using area measures of socio-economic status and geographic localization.
One strength of this study is that it is a population-based study with data from the Cô te d'Or breast and gynaecological cancer registry. Therefore, the results could be considered representative of women with BC living in the department during the period from 1998 to 2009. Another strength was the use of the FEDI, which is an ecological deprivation index constructed from the European survey. This index is specific to the context of European cultural and social policy and is suitable for assessing deprivation in the French population. It provides scores available for all the smallest units (MISI) of the entire French mainland and includes both objective and subjective poverty of the population, thus making it possible to consider deprivation as a whole. 19 The results of this study showed that living in a deprived area was linked to older age at diagnosis. Indeed, the socio-economic condition of elderly people is usually not as good as that of younger subjects. Some reports have highlighted the close relationship between old age and poor socio-economic status. 20, 21 Furthermore, living in deprived areas was associated with advanced stage at diagnosis, clinical diagnosis circumstances, the presence of comorbidities and living in an urban area. This could be explained by the lack of medical follow-up, which could be responsible for the advanced stage at diagnosis with clinical diagnosis.
Indeed, many studies have reported that living in the most deprived area was associated with a diagnosis of advanced or metastatic disease. 11, 20, 22, 23 Another finding was an unfavourable tumour stage in elderly women, which highlighted the impact of age on BC stage at diagnosis. [24] [25] [26] This could be explained by the delay in the diagnosis of BC due to fewer or no screening mammography examinations in older women. Moreover, as previously found, 27 older age was also associated with more clinical diagnoses than diagnoses on medical imaging, more comorbidities at diagnosis and a greater likelihood of living in an urban area than in a rural area.
However, according to age subgroup analysis, living in a deprived area was linked to an advanced stage at the diagnosis of BC only in women aged between 50 and 74 years. This result was also found in another study. 28 One explanation could be that women aged 50-74 years are eligible for BC organized screening. As found in this study, it has been showed that, women who were screened regularly were less likely to be detected with tumours of an advanced stage. 29 However, participation to BC screening programs decreased with increasing levels of socio-economic deprivation. [30] [31] [32] [33] Indeed, the most disadvantaged populations are less likely to take part in organized screening. Peek and Han 34 reported that vulnerable groups such as the poor, the elderly and minorities were often unaware of mammography screening programmes, had misconceptions regarding cancer, viewed mammography negatively and had fatalistic attitudes about cancer. Qualitative studies performed within populations in socio-economically disadvantaged neighbourhoods show a lack of information and/or a lack of awareness of disease prevention, diagnosis and treatment. Underestimation and a lack of anticipation of risks have also been noted among these populations. 35, 36 Like in other studies, our results also showed that advanced stage at diagnosis was not associated with increased travel time to a diagnosing facility or the nearest mammography facility. [37] [38] [39] The presence of comorbidities was linked to advanced stages at the diagnosis of BC as found in another study. 40 However, in older women, we did not find this result for comorbidities, this could be due to a lack of statistical power to identify a significant difference in this age group. Our results also showed that diagnosed from 2004 to 2009 was associated with a higher risk of advanced stages in older women compared to diagnosis before 2004. This can be explained by the fact that the introduction of organized BC screening programmes in 2004 for women aged 50-74 years could cause a later discovery of BC with advanced stages in women aged 75 years and older, because older women may not feel concerned by BC risk and thus will not go to be diagnosed at early stage.
In line with this study, many studies reported that RSR decreased with an increase in tumour stage at diagnosis, with an increase in the age of patients, with the presence of comorbidities, with the diagnosis by clinical signs. 27, 41 Moreover, lower socio-economic was associated with a poorer survival as found in others studies. 16, 20 The results of this study highlight the importance of considering age in studying the impact of socio-economic and geographic factors on tumour stage at the diagnosis in BC. Indeed, there were wide variations according to age groups regarding health concerns. Older women with BC were more likely to have comorbidities that could affect both cancer stage at diagnosis and access to care. Age can therefore interact with socio-economic and geographic determinants and hide their effects. In contrast, for women aged 50-74 years, the effect of socio-economic factors on disease stage at diagnosis was stronger, because these women were more likely to have been exposed to BC screening than were older or younger women. 42 The result of this study also showed that socio-economic status influenced BC survival; in contrast, there was no effect of geographic characteristics on BC survival. a: Medical imaging = opportunistic and organized screenings for patients aged 50-74 years and opportunistic screening for patients younger than 50 years and older than 74 years. 
Conclusions
This population-based study showed that socio-economic factors affected disease stage at diagnosis and survival. According to age, living in a deprived area was linked to an advanced stage at the diagnosis of BC only in women aged 50-74 years due probably to the impact of socio-economic disparities on participation in organized BC screening programmes. Furthermore, lower socioeconomic status was associated with a poor BC survival rate.
Background: More knowledge is needed about how various dimensions of social capital associate with mortality either independently or mediated by other factors. In this cohort study, individual-level social capital was assessed as a possible predictor of all-cause mortality. Methods: A 9-year mortality follow-up was conducted for participants of a nationally representative Health 2000 Survey carried out in 2000À01. The survey included a personal interview, self-administered questionnaires and a health examination. Response rates to different items varied between 80 and 88%. Due to the item non-response, missing values were replaced by using multiple imputation. Participants (N = 6377) were 30-79 years old at the baseline. During the follow-up period, 245 women and 340 men died. Cox regression models were used to assess the association between social capital and mortality. We analysed three dimensions of social capital: social support, social participation and trust. Their association with the risk of death was adjusted for several socio-demographic factors, health behaviours, health and biological risk factors. Results: Unactive social participation was associated with higher mortality risk even when adjusting for the other factors. The association was stronger among men [hazard ratio (HR) = 1.56] than women (HR = 1.42). The other two dimensions of social capital were associated with mortality when only age was adjusted for, but this association disappeared when social participation was included in the explanatory model. Conclusions: Active social participation protects against early death. This association is partly mediated through health behaviour and to a minor extent also through health. 
Introduction
S
everal studies have examined the association of sociodemographic factors, health behaviour, chronic illnesses and self-rated health (SRH) with mortality: people living alone, having a low education, low income, unhealthy lifestyle or poor SRH have higher mortality compared with those living with a partner, with higher education, high income, healthy lifestyle and good SRH, respectively. 1 Findings concerning the role of factors pertaining to social networks as determinants of mortality date back to the study of Berkman and Syme 2 who suggested that the association between social ties and mortality was independent of self-reported physical health status, socio-economic status, health habits, physical activity and utilization of preventive health services. Similar results have been reported later also under the concept of social capital.
Social capital is mostly viewed as a resource emerging from the relations and interaction between individuals and groups. The most essential elements are generally considered to be social participation and trust but other dimensions, such as social support, have been used, also. People get to know each other through participating in networks. People involved in associations and in cultural activities trust more in other people than the population on average. Trust facilitates social interaction and change of information between individuals. It also increases the likelihood of volunteering and civic engagement. [3] [4] [5] [6] [7] [8] As a multidimensional concept, social capital should be measured in a comprehensive manner including several dimensions. Social capital has been divided into structural (social and civic participation) and cognitive components (e.g. perceived social support, sense of belonging, norms, trust). Social networks can also be characterized as bonding (similar social identity), bridging (dissimilar social status) and linking (unequal power). In this study, we focus on both the structural (social participation) and cognitive (social support, trust and reciprocity) components of individual-level social capital.
High levels of social capital has been reported to be associated with better health [9] [10] [11] and a lower risk of mortality: For example, people attending cultural or social events have better survival compared with those who rarely attend such events. 12, 13 Lack of
